Q3 2018

2018 Third-Quarter Sales of $20.3 Billion Increased 3.6% versus 2017

2018 Third-Quarter EPS was $1.44

2018 Adjusted Third-Quarter EPS of $2.05 increased 7.9%*

Strong Operational Sales and Adjusted EPS Growth*

Company Increased Sales and EPS Guidance
“We are pleased with our strong third-quarter performance, which reflects continued above-market growth in our Pharmaceutical business, accelerating sales momentum in our Consumer business and consistent progress in our Medical Devices business,” said Alex Gorsky, Chairman and Chief Executive Officer. “I’m confident that with our collaborative and inspired J&J colleagues around the world, unique broad-based business model and strategic investments in innovation, we are well positioned for success today and into the future.”
Johnson & Johnson Reports 2018 Third-Quarter Results: | Johnson & Johnson

A Johnson & Johnson (NYSE: JNJ) divulgou seu resultado trimestral na terça-feira, 16 de outubro. A empresa divulgou lucro de US $ 2,05 por ação no trimestre, superando a estimativa de consenso do mercado, que era de US $ 2,03, por US $ 0,02. A companhia reportou receita de US $ 20,35 bilhões durante o trimestre, ao passo que a estimativa de consenso era de US $ 20,05 bilhões. A Johnson & Johnson teve um retorno sobre o patrimônio líquido de 32,79% e uma margem líquida de 1,70%. A receita da Johnson & Johnson no trimestre aumentou 3,6% na comparação ano a ano. Durante o mesmo período do ano anterior, a empresa reportou US $ 1,90 EPS.
NYSE:JNJ - Stock Price, News, & Analysis for Johnson & Johnson

Segue em velocidade de cruzeiro.

Johnson & Johnson (JNJ) Q3 2018 Results - Earnings Call Transcript

Johnson & Johnson (JNJ) Q3 2018 Results - Earnings Call Transcript | Seeking Alpha